Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of an Escherichia coli -derived human papillomavirus type 16 and 18 bivalent vaccine

20 Jul 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Hepatitis B Virus Studies
Share to Immunotherapy and Immune Responses

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28736197
DOI: 10.1016/j.vaccine.2017.06.084

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of an Escherichia coli -derived human papillomavirus type 16 and 18 bivalent vaccinePMID 28736197Read ↗

In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human PapillomavirusesSemantic proximity Read ↗

Developments in L2-based human papillomavirus (HPV) vaccinesSemantic proximity Read ↗

Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancerSemantic proximity Read ↗

Stability study of recombinant 9-valent human papillomavirus vaccine based on Escherichia coli expression systemSemantic proximity Read ↗

Phage-based vaccinesSemantic proximity Read ↗

A universal virus-like particle-based vaccine for human papillomavirus: Longevity of protection and role of endogenous and exogenous adjuvantsSemantic proximity Read ↗

First COVID-19 DNA vaccine approved, others in hot pursuitSemantic proximity Read ↗

Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trialSemantic proximity Read ↗

Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector systemSemantic proximity Read ↗

Characterization of novel bovine papillomavirus type 12 (BPV-12) causing epithelial papillomaSemantic proximity Read ↗

Human papillomavirus: current status and issues of vaccinationSemantic proximity Read ↗

The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coliSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.